First Turn Management’s CorMedix CRMD Stock Holding History

First Turn Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,021,421	Closed	-$8.27M	–	38
2024 Q4	$8.27M	Buy	+1,021,421	New	+$10.2M	1.48%	31

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

First Turn Management's CRMD Position: Q1 2025 in Review

First Turn Management sold out of CorMedix (CRMD) in Q1 2025, closing a stake of 1,021,421 shares — an estimated $8.27M sold.

First Turn Management first reported a position in CRMD in Q4 2024 and held it in 1 quarter. The position peaked at $8.27M in Q4 2024. 137 funds tracked by Wall St. Rank hold CRMD as of Q1 2025.

First Turn Management reported no remaining CorMedix position as of Q1 2025 after selling out during the quarter.
First Turn Management sold 1,021,421 CorMedix shares in Q1 2025, an estimated $8.27M.
First Turn Management first reported a position in CorMedix in Q4 2024 and held it in 1 quarter.
First Turn Management's CorMedix position peaked at $8.27M in Q4 2024.
137 funds tracked by Wall St. Rank held CorMedix as of Q1 2025.

Based on First Turn Management's 13F filing for Q1 2025, filed 15 May 2025.